To examine the effect of ANRIL-miR-181a-HMGB1 axis on gemcitabine chemotherapy for pancreatic cancer, we tested the effects of gemcitabine and the pathway on the proliferation of pancreatic cancer cells. This evidence concerns the gene CDKN2B-AS1 and familial pancreatic carcinoma.